The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
about
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TBImmune response to mycobacterial infection: lessons from flow cytometryA blood RNA signature for tuberculosis disease risk: a prospective cohort study.Tuberculosis in childhood: a systematic review of national and international guidelinesMycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests.Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.Diagnosis of childhood tuberculosis and host RNA expression in Africa.Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda.Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children.Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of thePotential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosisDetermining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis.Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children.Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard.Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative studyComparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.In vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection.Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs)Risk of developing tuberculosis after brief exposure in Norwegian children: results of a contact investigation.Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceUsefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children.The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infectionCost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in childrenIncremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis.Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infectionGamma interferon release assays for detection of Mycobacterium tuberculosis infection.Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.Diagnosis and management of TB in children: an update.Latent tuberculosis infection in children: diagnostic approaches.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis.How to use: interferon γ release assays for tuberculosis.Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countriesSystematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update.Transnational Record Linkage for Tuberculosis Surveillance and Program Evaluation.Childhood abdominal tuberculosis: Disease patterns, diagnosis, and drug resistance.Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008.
P2860
Q24201325-B4FF866C-3436-4C9F-B908-75624F245D80Q27002561-2791D7FC-83B8-48B4-97A4-5AB72CE60A32Q33566308-8F2C52D8-5BF7-4961-8CB1-60D891728C74Q33586737-74EC1B3F-0E3F-4FB5-B8F1-F0769B235F3CQ33690038-47E01D3D-E438-4E25-A2B8-C72798A1190CQ33801345-4D4ACBB7-706F-4136-AE9F-D5DE871C3F3BQ33803127-D3D9D8FB-349D-4B05-B60B-5D0E204F881DQ33880649-BB7416B5-3DE1-4918-A21F-C356B7A2A5E0Q33919057-E197811D-596B-4FBE-ADE8-23011B8DE5E1Q34047462-B1F31DC5-FE3A-4B06-9DC1-76AB161E4342Q34212799-074E183F-281C-4B3D-8329-AA3C76DD3B37Q34430676-D7E892C1-6E73-43D2-86EA-C7E6E47C9FFAQ34450737-2AFD1D25-C41E-4572-987A-56DB6585A96AQ35530896-703B2AAD-40D0-451E-936D-3FEFE68B7202Q35963484-1ACA38CC-67F7-4C18-9AB2-5D1D8C6A6D92Q36159344-ED74BB21-E882-41DC-85BD-23836BCF3DBFQ36174947-B2AE3469-D8DD-4C83-B5F7-8D2890C9C025Q36238265-D77AB73E-EAD7-40B4-83C6-741BEABA1E3CQ36301207-64B0A71B-71E5-4089-916E-FD873612F4B6Q36353973-EE2160AB-0932-46DF-9BFE-E383A43935C7Q36375791-BE774DC0-7898-4B1B-AEA9-8BDC4843F5A5Q36496334-9DBC8FCF-3072-49C8-BA79-F268D80B326CQ36637982-6FD80219-699F-417B-87BD-6E99A44AB1A9Q37121198-480400F0-E58E-4F04-AC05-E00D46441A6EQ37282511-5DE926B6-B702-4A4D-BF18-0E88A0201175Q37308287-57ABF716-70C4-4C2C-AD96-7E83FE63BF4AQ37391624-523E5310-9D30-49C3-9E6C-720BFDAEB3B7Q37471113-D378CF35-2F85-4B21-B87A-5631DDE0CA83Q37544916-DB04A885-AAB4-45AC-B502-EA132BBC599AQ37545069-1DE08235-A06E-4B32-A337-A297C9A5DEDBQ37960565-BD087C1E-9A5F-4491-AC4A-8F2DCD70F211Q37972997-A7F82899-600B-44CE-A52F-419D33AC5D7AQ37988577-C4EB06A2-677C-4E58-97C9-8691528C1A09Q38051443-3DA74C04-ECAB-4173-AB25-F777F98B5CC0Q38098496-07525B8D-3D83-462C-BC18-A6420762BD20Q38168333-EA13E69E-115B-4F16-91CE-1452123530E6Q38190587-25DA9687-C3AD-4418-832E-C6B95B5A1083Q38412754-851B862D-FBC9-4593-A585-E37720E7D875Q38672198-75411615-0119-42CD-81E6-B1490008738AQ38839155-B5763155-3459-445E-8262-0018AAEAB278
P2860
The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The utility of an interferon g ...... atic review and meta-analysis.
@en
The utility of an interferon g ...... atic review and meta-analysis.
@nl
type
label
The utility of an interferon g ...... atic review and meta-analysis.
@en
The utility of an interferon g ...... atic review and meta-analysis.
@nl
prefLabel
The utility of an interferon g ...... atic review and meta-analysis.
@en
The utility of an interferon g ...... atic review and meta-analysis.
@nl
P2093
P50
P921
P1476
The utility of an interferon g ...... atic review and meta-analysis.
@en
P2093
Hassan Mahomed
Shingai Machingaidze
Sizulu Moyo
Yulieth Gonzalez-Angulo
P304
P356
10.1097/INF.0B013E318214B915
P577
2011-08-01T00:00:00Z